We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Please enter your details into the form below to access the Webinar on ‘TNFR2 And PD1 Resistance‘. Hosted by Russell LaMontagne, Co-Founder and Chief Executive Officer, Boston Immune Technologies and Therapeutics.
Submit your details to receive this agenda & to be kept up to date about relevant events. You may opt-out at any time.
Please check our Privacy Policy to see how Oxford Global protects and manages your data.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.